ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Predictors of poor response to voice therapy in adult vocal fold nodules: a retrospective cohort study.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo identify predictors of poor response to standardized voice therapy in adult vocal fold nodules and to evaluate recurrence risk across treatment pathways.
methodsWe retrospectively reviewed 107 adults with vocal fold nodules treated between 2020 and 2024. Patients were categorized as: (i) voice therapy alone, (ii) delayed surgery after failed therapy, or (iii) primary surgery. Demographics, stroboscopic findings, acoustic and aerodynamic parameters, patient-reported outcomes (Voice Handicap Index-10, Vocal Fatigue Index), and clinician-rated perceptual evaluation (GRBAS) were analyzed. Therapy failure and recurrence were defined according to prespecified clinical criteria.
resultsVoice therapy was effective in 41/48 patients (85.4%). Compared with Group A, patients proceeding to delayed surgery had longer symptom duration, more professional voice use, and higher baseline shimmer and perceptual strain; 23/25 (92.0%) improved after surgery. Primary surgery patients had worse baseline measures; 30/34 (88.2%) improved but recurrence was higher (26.5%) than in delayed surgery (8.0%) or therapy alone (4.2%). On multivariable analysis, shimmer and VFI independently predicted therapy failure, while shimmer and GRBAS strain independently predicted recurrence.
conclusionStructured voice therapy remains first-line management. Elevated shimmer, perceptual strain, and high VFI identify patients at risk of failing conservative care and may justify earlier surgical consideration; professional voice use and longer symptom duration were associated on univariable analyses. Integrating objective acoustic and patient-reported measures can guide individualized decisions and clarify surgical indications.
Indexed as
Identifiers
41430451What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.